Thyroid function monitoring during pregnancy in euthyroid women with thyroid autoimmunity
Endocrine Connections · 05.07.2024 · 13 (9)
DOI: 10.1530/ec-24-0151 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Connections, erschienen am 05.07.2024. Verfasst von Aglaia Kyrilli und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hôpital Universitaire de Bruxelles (H.U.B.) - Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Thyroid autoimmunity (TAI) may be present in 1–17% of pregnant women. Monitoring of thyroid function in euthyroid pregnant women positive for anti-thyroperoxidase antibodies (TPOAb+) is recommended.
Objective
To determine the prevalence and possible clinical and biological risk factors of biochemical progression (rise in serum thyroid-stimulating hormone (TSH) > 2.5 mU/L) at second blood sampling during pregnancy, in euthyroid women (TSH ≤ 2.5 mU/L) according to their TPOAb status.
Methods
This study included demographic and biological data from two previously published cohorts ( n = 274 women from August 1996 to May 1997 Copenhagen cohort, and n = 66 women from January 2013 to December 2014 Brussels cohort) having at least two measurements of TSH and free thyroxine (FT4) and at least one of TPOAb during spontaneously achieved singleton pregnancies.
Results
The majority of women studied did not show biochemical progression. Only 4.2% progressed, significantly more frequently among TPOAb+ women, as compared to TPOAb− group (9.4 vs 2.7%, P = 0.015). No rise in serum TSH > 4 mU/L at 2nd sampling was observed. Higher baseline TSH levels were associated with biochemical progression in both TPOAb+ ( P = 0.05) and TPOAb− women ( P < 0.001), whereas maternal age, BMI, multiparity, smoking, FT4, and TPOAb concentrations were not significantly different between women with and without progression.
Conclusions
Only a minority of euthyroid women with thyroid autoimmunity presented biochemical progression and none with a TSH > 4 mU/L. Larger studies are needed to better target the subset of women who would benefit most from repeated thyroid function monitoring during pregnancy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Endocrinology, Hôpital Universitaire de Bruxelles (H.U.B.) - Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
- Department of Medical Endocrinology and Metabolism, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
- Department of Gynecology and Obstetrics, Copenhagen University Hospital (Hvidovre Hospital), Hvidovre, Denmark.
- Carelink Nærhospital, Roskilde, Denmark.
- Institute of Clinical Medicine, Faculty of Health and Clinical Research, Copenhagen University, Copenhagen, Denmark.
- Department of Endocrinology, Centre Hospitalier Universitaire Saint-Pierre, Brussels, Belgium.
ORCID-Profile: Aglaia Kyrilli
Zitieren
APA
Kyrilli, A., Corvilain, B., Bliddal, S., Precht, D. H., Feldt-Rasmussen, U., & Poppe, K. (2024). Thyroid function monitoring during pregnancy in euthyroid women with thyroid autoimmunity. Endocrine Connections, 13(9). https://doi.org/10.1530/ec-24-0151
Vancouver
Kyrilli A, Corvilain B, Bliddal S, Precht DH, Feldt-Rasmussen U, Poppe K. Thyroid function monitoring during pregnancy in euthyroid women with thyroid autoimmunity. Endocrine Connections. 2024;13(9). doi:10.1530/ec-24-0151
BibTeX
@article{Kyrilli2024,
author = {Kyrilli, Aglaia and Corvilain, Bernard and Bliddal, Sofie and Precht, Dorthe Hansen and Feldt-Rasmussen, Ulla and Poppe, Kris},
title = {Thyroid function monitoring during pregnancy in euthyroid women with thyroid autoimmunity},
journal = {Endocrine Connections},
year = {2024},
volume = {13},
number = {9},
doi = {10.1530/ec-24-0151}
}
EUVIMED